Hot Stock Commentary: MidWest One Financial Group (MOFG)

MidWestOne-Financial-Group-Inc.-logoMidWest One (MOFG) is our hot stock of the week and earns an Attractive rating. MidWest One, a smaller regional banking institution, had its ups and downs during 2014. The stock ended the year up only 3%, but was up 23% from its October lows. For many reasons, we feel MidWest One could be poised for a strong 2015.

Since 2009, MidWest One has grown after-tax profit (NOPAT) by 25% compounded annually. The company has increased its return on invested capital (ROIC) from 4% in 2009 to 8% last year. While MidWest One has not grown revenue from since 2011, maintaining strict control of expenses has allowed the company to continue growing NOPAT. However, through 3Q14, MidWest One has begun to grown revenue again to the tune of 4% over the same time period in 2013. This revenue growth puts MidWest One in an even better position to surpass expectations when it reports full year results.

Despite MidWest One’s impressive NOPAT growth, increasing ROIC, and revenue growth through 2014, its stock price remains deflated. At its current price of ~$28/share, MidWest One has a price to economic book value (PEBV) ratio of 0.7. This ratio implies the market expects MidWest One’s NOPAT to permanently decline by 30% from current levels. This seems highly pessimistic given MidWest One’s ability to grow NOPAT over the past five years, as well as its strong fundamental results so far through 2014.

Disclosure: New Constructs staff receive no compensation to write about any specific stock, sector, or theme.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Or Sign in with
Joe Economy 10 years ago Member's comment

Since it's being bounced around so much everywhere, would love to hear your thoughts on safe stock tips for an impending market crash. Any thoughts on these supposed safe haven stocks? STZ - one of the world's leading wine, beer, and spirits companies, and ACT, one of the world's leading generic drug makers? What are your suggestions? Thanks for your input.